GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Intelgenx Technologies Corp (OTCPK:IGXT) » Definitions » Shiller PE Ratio

Intelgenx Technologies (Intelgenx Technologies) Shiller PE Ratio : (As of Apr. 29, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Intelgenx Technologies Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Intelgenx Technologies Shiller PE Ratio Historical Data

The historical data trend for Intelgenx Technologies's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intelgenx Technologies Shiller PE Ratio Chart

Intelgenx Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Intelgenx Technologies Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Intelgenx Technologies's Shiller PE Ratio

For the Biotechnology subindustry, Intelgenx Technologies's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Intelgenx Technologies's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Intelgenx Technologies's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Intelgenx Technologies's Shiller PE Ratio falls into.



Intelgenx Technologies Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Intelgenx Technologies's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Intelgenx Technologies's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.01/125.4675*125.4675
=-0.010

Current CPI (Dec. 2023) = 125.4675.

Intelgenx Technologies Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -0.010 98.604 -0.013
201406 -0.010 99.473 -0.013
201409 -0.010 99.394 -0.013
201412 0.000 98.367 0.000
201503 -0.001 99.789 -0.001
201506 -0.004 100.500 -0.005
201509 0.020 100.421 0.025
201512 0.000 99.947 0.000
201603 -0.010 101.054 -0.012
201606 -0.010 102.002 -0.012
201609 0.000 101.765 0.000
201612 0.000 101.449 0.000
201703 -0.010 102.634 -0.012
201706 -0.010 103.029 -0.012
201709 -0.010 103.345 -0.012
201712 -0.020 103.345 -0.024
201803 -0.030 105.004 -0.036
201806 -0.040 105.557 -0.048
201809 -0.040 105.636 -0.048
201812 -0.030 105.399 -0.036
201903 -0.030 106.979 -0.035
201906 -0.030 107.690 -0.035
201909 -0.030 107.611 -0.035
201912 -0.030 107.769 -0.035
202003 -0.030 107.927 -0.035
202006 -0.010 108.401 -0.012
202009 -0.010 108.164 -0.012
202012 -0.020 108.559 -0.023
202103 -0.020 110.298 -0.023
202106 -0.020 111.720 -0.022
202109 -0.010 112.905 -0.011
202112 -0.020 113.774 -0.022
202203 -0.020 117.646 -0.021
202206 -0.020 120.806 -0.021
202209 -0.020 120.648 -0.021
202212 -0.010 120.964 -0.010
202303 -0.020 122.702 -0.020
202306 -0.020 124.203 -0.020
202309 -0.010 125.230 -0.010
202312 -0.010 125.468 -0.010

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Intelgenx Technologies  (OTCPK:IGXT) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Intelgenx Technologies Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Intelgenx Technologies's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Intelgenx Technologies (Intelgenx Technologies) Business Description

Traded in Other Exchanges
Address
6420 Abrams, Ville Saint Laurent, QC, CAN, H4S 1Y2
Intelgenx Technologies Corp is an oral drug delivery company. The company is focused on the development and manufacturing of pharmaceutical oral films based on its proprietary VersaFilmTM technology platform. Intelegenx focuses on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market. It offers a comprehensive portfolio of pharmaceutical services, including pharmaceutical R&D, clinical monitoring, regulatory support, tech transfer and manufacturing scale-up, and commercial manufacturing. Its geographical segments are Europe, Canada, and United States.
Executives
Atai Life Sciences Ag 10 percent owner KRAUSENSTRASSE 9-10, BERLIN 2M 10117
Atai Life Sciences N.v. 10 percent owner 524 BROADWAY, NEW YORK NY 10013
Karen Kalayajian officer: VP, Finance&Admin - Subsidiary 4896 RUE EDOUARD-BRUNETTE, LAVAL A8 H7T 0J4
Dwight Gorham officer: CEO 15B BARKLEY ST, ARNPRIOR A6 K7S 3G8
David Kideckel officer: SVP, Corp. Dev&SA - Subsidiary 23 PEVERIL HILL SOUTH, TORONTO, ON A6 M6C 3A7
Horst G Zerbe 10 percent owner, officer: Chief Executive Officer 714 MAIN ROAD, HUDSON A8 JOP1H0
Andre Godin officer: CFO 440 DES CARMANTINES, LAVAL A8 H7X 0B6
Tommy Kenny officer: VP IP,Lgl Affairs - Subsidiary 88 CH. DES SAULES, ST-ADOLPHE D' HOWARD A8 J0T 2B0
Dana Matzen officer: VP Business+Corp. Development 4771 RUE SHERBROOKE O., WESTMOUNT A8 H3Z1G5
Ingrid Zerbe 10 percent owner, officer: Corporate Secretary 714 MAIN ROAD, HUDSON A8 J0P1H0
Rodolphe Obeid officer: Vice President, Operations 4779 RUE VILLERET, PIERREFOND A8 H9K1P6
Bernard Boudreau director 2 TURNMILL DR., HALIFAX A5 B3M4H2
John Edward Durham officer: Vice President Manufacturing 102 MAYFAIR, HUDSON A8 J0P1H0
Mark Nawacki director 118 ARLINGTON AVENUE, WESTMOUNT A8 H3Y2W4
Robert J. Bechard officer: VP Corporate Development 141 EASTON AVENUE, MONTREAL WEST A8 H4X 1L4

Intelgenx Technologies (Intelgenx Technologies) Headlines